Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -435,798 | -302,282 | -170,684 | -607,000 | -483,449 |
| Depreciation Amortization | 16,646 | 11,004 | 5,089 | 13,000 | 8,894 |
| Accounts receivable | -12,958 | -22,750 | -24,908 | -23,000 | -23,790 |
| Other Working Capital | -8,833 | -39,661 | -56,019 | -16,000 | -28,405 |
| Other Operating Activity | 106,258 | 85,999 | 55,795 | 158,000 | 135,848 |
| Operating Cash Flow | $-334,685 | $-267,690 | $-190,727 | $-475,000 | $-390,902 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -98,857 | 171,803 | 109,711 | 221,000 | 324,961 |
| PPE Investments | -6,837 | -5,220 | -3,211 | -44,000 | -42,667 |
| Sale Of Investment | N/A | 3,022 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -12,500 | -12,500 | -10,000 | -3,000 | -2,500 |
| Other Investing Activity | -14,809 | -14,606 | -12,065 | -9,000 | -7,277 |
| Investing Cash Flow | $-120,503 | $154,999 | $94,435 | $168,000 | $275,017 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 396,055 | 384,881 | -58 | 387,000 | 57,560 |
| Other Financing Activity | 0 | 0 | 0 | 1,000 | -28 |
| Financing Cash Flow | $396,055 | $384,881 | $-58 | $388,000 | $57,532 |
| Exchange Rate Effect | -52 | -1,327 | -679 | N/A | -641 |
| Beginning Cash Position | 219,399 | 219,399 | 219,399 | 138,000 | 137,601 |
| End Cash Position | 160,214 | 490,262 | 122,370 | 219,000 | 78,607 |
| Net Cash Flow | $-59,185 | $270,863 | $-97,029 | $81,000 | $-58,994 |
| Free Cash Flow | |||||
| Operating Cash Flow | -334,685 | -267,690 | -190,727 | -475,000 | -390,902 |
| Capital Expenditure | -6,837 | -5,220 | -3,211 | -44,000 | -42,667 |
| Free Cash Flow | -341,522 | -272,910 | -193,938 | -519,000 | -433,569 |